{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T01:29:55Z","timestamp":1787016595582,"version":"build-2736575974"},"reference-count":33,"publisher":"American Society for Microbiology","issue":"8","license":[{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T00:00:00Z","timestamp":1723593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2024,8,14]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      The PATHFAST TB LAM Ag assay is based on a chemiluminescent enzyme immunoassay to quantify lipoarabinomannan (LAM) in sputum within 1 h, and was developed as an alternative to conventional culture methods for monitoring tuberculosis (TB) treatment. This study aimed to evaluate the analytical performance and initial clinical feasibility of using five\n                      <jats:italic>Mycobacterium tuberculosis<\/jats:italic>\n                      variants, 178 non-tuberculous mycobacteria (NTM), 34 upper respiratory and oral cavity microorganisms, 100 sputum specimens from untreated patients, and potential interfering substances, including 27 drugs. The results reveled a single-site repeatability coefficient of variation (CV) of 5.2%\u20137.0%, and a multi-site reproducibility CV of 7.1%\u20138.4%. The limit of blank, limit of detection, and limit of quantification were 3.03 pg\/mL, 6.67 pg\/mL, and 7.44 pg\/mL, respectively. Linearity was observed over the analytical measurement range (10.0 pg\/mL\u201350,000 pg\/mL), and no hook effect was observed. The assay tended to cross-react with slow-growing NTMs, but not with common upper respiratory and oral cavity microorganisms, except\n                      <jats:italic>Nocardia asteroides<\/jats:italic>\n                      ,\n                      <jats:italic>Nocardia farcinica<\/jats:italic>\n                      , and\n                      <jats:italic>Tsukamurella paurometabola<\/jats:italic>\n                      . No interference was observed in the presence of mucin, blood, or major anti-TB, anti-HIV, and anti-pneumonia drugs. Regarding clinical performance, the assay had a sensitivity of 88.8% (95% CI: 80.0%\u201394.0%) and specificity of 100.0% (95% CI: 83.9%\u2013100.0%) using mycobacterial culture as the reference standard, and a correlation (Spearman\u2019s\n                      <jats:italic>r<\/jats:italic>\n                      = \u22120.770) was observed between LAM concentration and time to detection of culture. These findings show, for the first time, that the PATHFAST TB LAM Ag assay has potential value for monitoring TB treatment.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1128\/jcm.00629-24","type":"journal-article","created":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T09:00:27Z","timestamp":1721379627000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":15,"title":["Development and preliminary evaluation toward a new tuberculosis treatment monitoring tool: the PATHFAST TB LAM Ag assay"],"prefix":"10.1128","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2569-2827","authenticated-orcid":true,"given":"Ayumi","family":"Akinaga","sequence":"first","affiliation":[{"name":"PHC Corporation, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahito","family":"Takahashi","sequence":"additional","affiliation":[{"name":"PHC Corporation, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Yamazaki","sequence":"additional","affiliation":[{"name":"PHC Corporation, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinuyo","family":"Chikamatsu","sequence":"additional","affiliation":[{"name":"Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3782-664X","authenticated-orcid":false,"given":"Shuhei","family":"Matsushita","sequence":"additional","affiliation":[{"name":"PHC Corporation, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9788-7898","authenticated-orcid":false,"given":"Yuichiro","family":"Hashimoto","sequence":"additional","affiliation":[{"name":"PHC Corporation, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Iyoda","sequence":"additional","affiliation":[{"name":"LSI Medience Corporation, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Saika","sequence":"additional","affiliation":[{"name":"LSI Medience Corporation, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2288-077X","authenticated-orcid":true,"given":"Satoshi","family":"Mitarai","sequence":"additional","affiliation":[{"name":"Department of Mycobacterium Reference and Research, The Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_4_4_2","volume-title":"Target product profiles for test for tuberculosis treatment monitoring and optimization","author":"World Health Organization (WHO)","year":"2023","unstructured":"World Health Organization (WHO). 2023. Target product profiles for test for tuberculosis treatment monitoring and optimization. Geneva, Switzerland."},{"key":"e_1_3_4_5_2","volume-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug- susceptible tuberculosis treatment","author":"World Health Organization (WHO)","year":"2022","unstructured":"World Health Organization (WHO). 2022. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug- susceptible tuberculosis treatment. Geneva, Switzerland."},{"key":"e_1_3_4_6_2","volume-title":"WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update","author":"World Health Organization (WHO)","year":"2022","unstructured":"World Health Organization (WHO). 2022. WHO consolidated guidelines on tuberculosis. Module 4: treatment - drug-resistant tuberculosis treatment, 2022 update. Geneva, Switzerland."},{"key":"e_1_3_4_7_2","volume-title":"Treatment of tuberculosis guidelines","author":"World Health Organization (WHO)","year":"2010","unstructured":"World Health Organization (WHO). 2010. Treatment of tuberculosis guidelines. 4th ed. Geneva, Switzerland.","edition":"4"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw376"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00059-10"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.17.0629"},{"key":"e_1_3_4_11_2","first-page":"211","article-title":"Quality assessment of smear microscopy by stratified lot sampling of treatment follow-up slides","volume":"15","author":"Otero L","year":"2011","unstructured":"Otero L, Van Deun A, Agapito J, Ugaz R, Prellwitz G, Gotuzzo E, Van der Stuyft P. 2011. Quality assessment of smear microscopy by stratified lot sampling of treatment follow-up slides. Int J Tuberc Lung Dis 15:211\u2013216.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8038137"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6963-13-392"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198947"},{"key":"e_1_3_4_15_2","volume-title":"Handbook on tuberculosis laboratory diagnostic methods in the European union, updated 2022","author":"European center for disease prevention and control (ECDC)","year":"2023","unstructured":"European center for disease prevention and control (ECDC). 2023. Handbook on tuberculosis laboratory diagnostic methods in the European union, updated 2022. Stockholm, Sweden."},{"key":"e_1_3_4_16_2","volume-title":"Tuberculosis laboratory biosafety manual","author":"World health Organization (WHO)","year":"2012","unstructured":"World health Organization (WHO). 2012. Tuberculosis laboratory biosafety manual. Geneva, Switzerland."},{"key":"e_1_3_4_17_2","first-page":"138","article-title":"Risk of occupational tuberculosis in national tuberculosis programme laboratories in Korea","volume":"11","author":"Kim SJ","year":"2007","unstructured":"Kim SJ, Lee SH, Kim IS, Kim HJ, Kim SK, Rieder HL. 2007. Risk of occupational tuberculosis in national tuberculosis programme laboratories in Korea. Int J Tuberc Lung Dis 11:138\u2013142.","journal-title":"Int J Tuberc Lung Dis"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1586\/17476348.2016.1166960"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00227-21"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.3349\/ymj.1990.31.4.333"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.6.2278-2283.2000"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002780"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-022-07308-3"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011420.pub2"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9010111"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(22)00463-6"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.30.9.2415-2418.1992"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(10)70071-2"},{"key":"e_1_3_4_29_2","volume-title":"Evaluation of precision of quantitative measurement procedures, approved guidlineCLSI Document EP05-A3","author":"Clinical and Laboratory Standards Institute","year":"2014","unstructured":"Clinical and Laboratory Standards Institute. 2014. Evaluation of precision of quantitative measurement procedures, approved guidline. 3rd ed. CLSI Document EP05-A3. Wayne, USA.","edition":"3"},{"key":"e_1_3_4_30_2","volume-title":"Evaluation of detection capability for clinical laboratory measurement procedures, approved guidlineCLSI Document EP17-A2","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute. 2012. Evaluation of detection capability for clinical laboratory measurement procedures, approved guidline. 2nd ed. CLSI Document EP17-A2. Wayne, USA.","edition":"2"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.18535\/jmscr\/v5i8.86"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.789725"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-021-00975-y"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.55.10.778"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01778-18"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jctube.2016.05.005"}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00629-24","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/jcm.00629-24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T09:02:24Z","timestamp":1723626144000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/jcm.00629-24"}},"subtitle":[],"editor":[{"given":"Christine Y.","family":"Turenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,8,14]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,14]]}},"alternative-id":["10.1128\/jcm.00629-24"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00629-24","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"value":"0095-1137","type":"print"},{"value":"1098-660X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,14]]},"assertion":[{"value":"2024-04-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-19","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-07-19","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00629-24"}}